(Q48543545)

12 February 2018

title

Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs (English)

1 reference

12 February 2018

0 references

8

1 reference

12 February 2018

Helen Tremlett

9

1 reference

12 February 2018

Mia L van der Kop

4

object named as

Mia van der Kop

1 reference

12 February 2018

Ellen Lu

1

1 reference

12 February 2018

Feng Zhu

2

1 reference

12 February 2018

Yinshan Zhao

3

1 reference

12 February 2018

Anne Synnes

5

1 reference

12 February 2018

Leanne Dahlgren

6

1 reference

12 February 2018

A Dessa Sadovnick

7

1 reference

12 February 2018

publication date

1 May 2014

1 reference

12 February 2018

published in

CNS Drugs

1 reference

12 February 2018

volume

28

1 reference

12 February 2018

issue

5

1 reference

12 February 2018

page(s)

475-482

1 reference

12 February 2018

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

1 reference

Diagnosis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Gynecomastia and semen abnormalities induced by spironolactone in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Asthenospermia in hay fever patients improved by stopping treatment with histamine H1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Parenthood and immunomodulation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Pregnancy, sex and hormonal factors in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Diagnostic criteria for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

21 January 2018

Outcomes of multiplets

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Age terminology during the perinatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

The clinical content of preconception care: preconception care for men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Evidence for a role of paternal exposures in developmental toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Paternal exposure to drugs and environmental chemicals: effects on progeny outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Endocrine disruptors, environmental oxygen, epigenetics and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Birth outcomes of pregnancies fathered by men with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Parental smoking habits and infant birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Coeliac disease in the father and risk of adverse pregnancy outcome: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0154-6

Psoriasis, methotrexate, and oligospermia

21 January 2018

1 reference

12 December 2020

Malformed foetuses and karyotype abnormalities in the offspring of cyclophosphamide and allyl alcohol-treated male rats

1 reference

12 December 2020

Effects of limited paternal exposure to xenobiotic agents on the development of progeny.

1 reference

12 December 2020

Prevalence of multiple sclerosis in British Columbia

1 reference

12 December 2020

Life expectancy in patients attending multiple sclerosis clinics

1 reference

12 December 2020

A proposal for a new method of evaluation of the newborn infant

1 reference

12 December 2020

10.1007/S40263-014-0154-6

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018